Træning og vitamin D-stofskifte (Hybri-D)
Effekten af hybrid-type højintensiv intervaltræning på D-vitaminomsætningen hos voksne med overvægt/fedme
The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D [25(OH)D] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Thirty adults with overweight/obesity (both males and females) who will meet the inclusion criteria will be randomly assigned to either an Exercise group (n=15) or a Control group (n=15). The Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet. The Control group will receive a balanced diet but will not participate in exercise training. Both groups will provide a resting blood sample and undergo assessment of their body composition (via bioelectrical impedance analysis), daily dietary intake (via dietary recalls) and physical activity level (via accelerometry) at baseline (prior to intervention), 6 weeks and 12 weeks.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Dimitrios Draganidis, PhD
- Telefonnummer: +302431047078
- E-mail: ddraganidis@uth.gr
Undersøgelse Kontakt Backup
- Navn: Ioannis G Fatouros, PhD
- Telefonnummer: 2431047047
- E-mail: ifatouros@uth.gr
Studiesteder
-
-
Karyes
-
Trikala, Karyes, Grækenland, 42100
- Rekruttering
- Department of Physical Education and Sport Science, University of Thessaly
-
Kontakt:
- Ioannis G Fatouros, PhD
- Telefonnummer: 2431047047
- E-mail: ifatouros@uth.gr
-
Kontakt:
- Athanasios Z Jamurtas, PhD
- Telefonnummer: 2431047054
- E-mail: ajamurt@uth.gr
-
Underforsker:
- Eytychia Giouvri, BSc
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- BMI = 25-35 kg/m2
- Absence of musculoskeletal injuries
- Absence of chronic health-related complications
- Non-smokers
Exclusion Criteria:
- Consumption of Vitamin D supplements
- Consumption of anti-inflammatory drugs, statins and/or steroids
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Exercise group
Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet |
Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period |
|
Aktiv komparator: Control group
Control group will receive a balanced diet but will not participate in exercise training |
Receive a balanced diet but abstain from any type of exercise training |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in 25-hydroxyvitamin D concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
25-OH-VD will be quantitatively determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in plasma Vitamin D binding protein concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Vitamin D binding protein concentration will be determined in plasma |
At baseline, 6 weeks and 12 weeks
|
|
Change in calcium concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Calcium concentration will be determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in albumin concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Albumin concentration will be determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in aspartate aminotransferase (SGOT) concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
SGOT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
|
Change in alanine aminotransferase (SGPT) concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
SGPT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
|
Change in gamma-glutamyl transferase (γ-GT) concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
γ-GT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in reduced glutathione concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Reduced glutathione concentration will be determined in blood erythrocytes |
At baseline, 6 weeks and 12 weeks
|
|
Change in oxidized glutathione concentration
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Oxidized glutathione concentration will be determined in blood erythrocytes |
At baseline, 6 weeks and 12 weeks
|
|
Change in dietary intake
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Dietary intake habits will be assessed through dietary recalls |
At baseline, 6 weeks and 12 weeks
|
|
Change in physical activity level
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Physical activity will be assessed via accelerometry |
At baseline, 6 weeks and 12 weeks
|
|
Change in body composition
Tidsramme: At baseline, 6 weeks and 12 weeks
|
Body composistion will be assessed via bioelectrical impedance analysis (BIA) |
At baseline, 6 weeks and 12 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Dimitrios Draganidis, PhD, University of Thessaly
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- UTH_2612_8.10.2025
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .